Related Experiment Video
Updated: Oct 16, 2025
08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.6K
A Primer on Chimera Associated Receptor T-Cells
Sumalatha Muthineni1, Katelyn Zink2, Suman Kambhampati2
1Internal Medicine, Hematology/Oncology, practice at the Sarah Cannon Transplant and Cellular Therapy Program, Research Medical Center, Kansas City, Missouri.
Missouri Medicine
|October 18, 2021
Summary
Chimeric Antigen Receptor (CAR) T-cell therapy offers a promising new approach for treating difficult blood cancers. This immunotherapy involves genetically engineering T-cells to target and destroy cancer cells, showing potential for curative responses.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer remains a leading cause of death globally.
- Hematological malignancies with relapsed or refractory disease have a poor prognosis despite current treatments.
- Immunotherapy presents a hopeful avenue for achieving curative responses in cancer patients.
Purpose of the Study:
- To discuss the fundamental principles of Chimeric Antigen Receptor (CAR) T-cell therapy.
- To highlight the emerging role of CAR T-cell therapy in treating hematological malignancies.
- To mention the ongoing investigation of CAR T-cell therapy's efficacy in solid tumors.
Main Methods:
- Review of existing literature on CAR T-cell therapy.
- Explanation of the genetic engineering process for T-lymphocytes.
- Discussion of CAR T-cell mechanisms against tumor cells.
Main Results:
- CAR T-cell therapy is an emerging and promising treatment for hematological malignancies.
- T-lymphocytes engineered with CAR can specifically recognize and eliminate tumor cells.
- Research is expanding to evaluate CAR T-cell therapy's effectiveness in solid tumors.
Conclusions:
- CAR T-cell therapy represents a significant advancement in cancer immunotherapy.
- The principles of CAR T-cell therapy are crucial for understanding its application and potential.
- Further research is warranted to optimize and broaden the application of CAR T-cell therapy.
